(Q42538440)

1 November 2017

title

Cardiotoxicity of doxorubicin: effects of 21-aminosteroids (English)

1 reference

1 November 2017

1 reference

Falcone G

1

1 reference

1 November 2017

Filippelli W

2

1 reference

1 November 2017

Mazzarella B

3

1 reference

1 November 2017

Tufano R

4

1 reference

1 November 2017

Mastronardi P

5

1 reference

1 November 2017

Filippelli A

6

1 reference

1 November 2017

Berrino L

7

1 reference

1 November 2017

Rossi F

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

1 November 2017

1 reference

1 November 2017

volume

63

1 reference

1 November 2017

issue

17

1 reference

1 November 2017

page(s)

1525-1532

1 reference

Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans)

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Lazaroids. CNS pharmacology and current research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Influence of the 21-aminosteroid U74389F on ischemia-reperfusion injury in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Protective Effects of a Novel Nonglucocorticoid 21-Aminosteroid (U74006F) During Traumatic Shock in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Anthracycline-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Acute arrhythmogenicity of doxorubicin administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Cardiotoxicity of adriamycin and related anthracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Doxorubicin-induced congestive heart failure in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Mitochondrial regulation of superoxide by Ca2+: An alternate mechanism for the cardiotoxicity of doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

A digitized-fluorescence-imaging study of mitochondrial Ca2+ increase by doxorubicin in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Importance of pharmacologic considerations in the evaluation of new treatments for acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Diquat-induced oxidative damage in hepatic microsomes: Effects of antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Cardiotoxicity of doxorubicin: effects of drugs inhibiting the release of vasoactive substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900419-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(98)00419-6

1 reference

1 November 2017

1 reference